Concepedia

Mirjana Rajer

MR

Statistics

Publications

9

Citations

187

H-Index

9

Active since

2005

Affiliations

Institute of Oncology Ljubljana(Current)

University Clinic of Pulmonary and Allergic Diseases Golnik

University of Maribor

Mirjana Rajer is an author at Institute of Oncology Ljubljana specializing in medicine, oncology, and non-small cell lung cancer therapy.

Publications per year

2005–2022

9

Publications

9

A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma

Viljem Kovač, Matjaž Zwitter, Mirjana Rajer et al. · Anti-Cancer Drugs · 2011 · 41 citations

, , +16

Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial

Matjaž Zwitter, Viljem Kovač, Mirjana Rajer et al. · Anti-Cancer Drugs · 2010 · 30 citations

, , +13

Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations

Matjaž Zwitter, Mirjana Rajer, Karmen Stanič et al. · Cancer Biology & Therapy · 2016 · 27 citations · Full text

, , +17

Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment

Abed Agbarya, Walid Shalata, Alfredo Addeo et al. · Journal of Clinical Medicine · 2022 · 18 citations · Full text

, , +17

Malignant spinal cord compression

Mirjana Rajer, Vilijem Kovač · Radiology and Oncology · 2008 · 17 citations · Full text

, , +16

1–5 of 9